KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Inventory (2016 - 2025)

Historic Inventory for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $2.8 billion.

  • Bristol Myers Squibb's Inventory fell 1722.69% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year decrease of 1722.69%. This contributed to the annual value of $2.6 billion for FY2024, which is 394.44% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Inventory of $2.8 billion as of Q3 2025, which was down 1722.69% from $2.7 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Inventory ranged from a high of $3.3 billion in Q3 2024 and a low of $2.0 billion during Q1 2021
  • Over the past 5 years, Bristol Myers Squibb's median Inventory value was $2.4 billion (recorded in 2023), while the average stood at $2.5 billion.
  • In the last 5 years, Bristol Myers Squibb's Inventory crashed by 3113.54% in 2021 and then skyrocketed by 3678.16% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Inventory stood at $2.1 billion in 2021, then increased by 11.65% to $2.3 billion in 2022, then rose by 13.81% to $2.7 billion in 2023, then dropped by 3.94% to $2.6 billion in 2024, then increased by 7.86% to $2.8 billion in 2025.
  • Its Inventory was $2.8 billion in Q3 2025, compared to $2.7 billion in Q2 2025 and $2.7 billion in Q1 2025.